Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000755348 | SCV000604777 | benign | Polycystic kidney disease, adult type | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000253222 | SCV001476611 | benign | not specified | 2020-02-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001573560 | SCV001941236 | benign | not provided | 2020-03-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 17574468, 18640754, 22383692, 18837007, 22008521) |
Ce |
RCV001573560 | SCV004142882 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | PKD1: BP4, BS2 |
Breakthrough Genomics, |
RCV001573560 | SCV005219002 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003891870 | SCV000305742 | benign | PKD1-related disorder | 2019-10-01 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Department of Pathology and Laboratory Medicine, |
RCV000253222 | SCV000592775 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001573560 | SCV001799613 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000253222 | SCV001927662 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001573560 | SCV001976071 | likely benign | not provided | no assertion criteria provided | clinical testing |